"We would encourage you to visit www.coronavirus.gov for the latest information and guidance related to COVID-19"
Speakers
Pre-Registration closes on: February 3, 2023
Get your pass now until price go up & save 40%
Walter Straus, MD, MPH, FACP
Vice-President, Clinical Safety, Moderna
Jay A. Berzofsky, MD.,Ph.D
Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute
Alessandro Sette, Dr.Biol.Sci.
Professor, Center for Autoimmunity and Inflammation, Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Ofer Levy, MD, PhD
Staff Physician & Principal Investigator, Director, Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital Professor, Harvard Medical School
Hanneke Schuitemaker, PhD
VP, Head of Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines and Prevention B.V.
Karin Bok, MS, PhD
Acting Deputy Director, Director of Pandemic Preparedness and Emergency Response, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Mary Marovich, MD, FACP, DTMH
NIH, NIAID, Division of AIDS, Director, Vaccine Research Program
Dan Barouch, M.D., Ph.D.
William Bosworth Castle Professor of Medicine, Harvard Medical School, Ragon Institute of MGH, MIT, and Harvard, Director, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center
David B. Weiner, Ph.D.
Executive Vice President, The Wistar Institute, Director, Vaccine & Immunotherapy Center
Marco Pravetoni, Ph.D.
Professor of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Director, Center for Medication Development for Substance Use Disorders and Overdose
Alexander Bukreyev, Ph.D.
Professor, Co-Principal Investigator Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus, Departments of Pathology and Microbiology & Immunology, Galveston National Laboratory, University of Texas Medical Branch
Rama Rao Amara, Ph.D.
Charles Howard Candler Professor, Department of Microbiology and Immunology, Associate Director, Vaccine Development, Emory Vaccine Center, Co-Director, Developmental Core, Emory CFAR, Emory National Primate Research Center, Emory University
Robert O. Dillman, M.D.
Chief Medical Officer, AIVITA Biomedical, Inc., Clinical Professor of Medicine, UC Irvine
Magdalena Tary-Lehmann, M.D., Ph.D.
Chief Scientific Officer, Cellular Technology Limited, Adjunct Associate Professor of Pathology, Case Western Reserve University
Shahin Gharakhanian, MD, DPH
Pharmaceutical Medicine, Infectious Diseases, Member, IDSA: Infectious Diseases Society of America. Shahin Gharakhanian MD Consulting LLC
Christopher Rudd, PhD, DSc, FRSC
Professeur, Faculte de Medicine, Dept de microbiologie, infectiologie et immunologie, Director-Cell Signaling and Immunotherapy Section, Centre de Recherche Hopital Maisonneuve-Rosemont
Jonathan Lovell, Ph.D.
SUNY Empire Innovation Associate Professor, Department of Biomedical Engineering, Jacobs School of Medicine & Biomedical Sciences, University of Buffalo